Neointima

Neointima

The term neointima refers to the new tissue that forms on the inner surface of a blood vessel following an injury or surgical intervention, such as angioplasty or stent placement. This process is a part of the body's natural healing response but can lead to complications such as restenosis, where the vessel becomes narrowed again due to excessive tissue growth.

Formation of Neointima

Neointima formation is a complex biological process that involves several stages:

Endothelial Injury

The process begins with injury to the endothelial cells lining the blood vessel. This can occur due to mechanical damage from procedures like balloon angioplasty or stent deployment.

Inflammatory Response

Following endothelial injury, an inflammatory response is triggered. This involves the recruitment of inflammatory cells such as macrophages and lymphocytes to the site of injury. These cells release cytokines and growth factors that promote healing.

Smooth Muscle Cell Proliferation

One of the key events in neointima formation is the proliferation and migration of vascular smooth muscle cells (VSMCs) from the media layer of the vessel wall to the intima. These cells contribute to the thickening of the vessel wall.

Extracellular Matrix Production

VSMCs and other cells produce extracellular matrix components, such as collagen and elastin, which provide structural support to the newly formed tissue.

Clinical Implications

Neointima formation is a double-edged sword. While it is essential for healing, excessive neointimal hyperplasia can lead to restenosis, which is the re-narrowing of the blood vessel. This is a significant concern in patients who have undergone procedures to open blocked arteries, such as coronary artery stenting.

Restenosis

Restenosis is a major limitation of percutaneous coronary interventions. It occurs in a significant percentage of patients and often requires repeat procedures. Drug-eluting stents and other pharmacological strategies have been developed to mitigate this risk by inhibiting VSMC proliferation and neointimal hyperplasia.

Research and Developments

Ongoing research is focused on understanding the molecular mechanisms underlying neointima formation and developing new therapies to prevent restenosis. This includes the study of gene expression changes, signaling pathways, and the role of specific cytokines and growth factors.

Also see

• Endothelial cells
• Vascular smooth muscle cells
• Restenosis
• Angioplasty
• Stent

Resources

Latest articles - Neointima

• Most recent articles
• Ongoing trials

Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Neointima for any updates.

‎

Cardiovascular disease A-Z

Most common cardiac diseases

• Cardiac arrhythmia‎
• Cardiogenetic disorders‎
• Cardiomegaly‎
• Cardiomyopathy‎
• Cardiopulmonary resuscitation‎
• Chronic rheumatic heart diseases‎
• Congenital heart defects‎
• Heart neoplasia‎
• Ischemic heart diseases‎
• Pericardial disorders
• Syndromes affecting the heart‎
• Valvular heart disease‎

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

A

• Accelerated idioventricular rhythm
• Acute decompensated heart failure
• Arteriosclerotic heart disease
• Athletic heart syndrome
• Atrial flutter
• Atrioventricular fistula
• Cardiovascular disease in Australia
• Autoimmune heart disease

B

• Brown atrophy of the heart

C

• Ebb Cade
• Cardiac allograft vasculopathy
• Cardiac amyloidosis
• Cardiac asthma
• Cardiac tamponade
• Cardiogenic shock
• Cardiogeriatrics
• Cardiorenal syndrome
• Cardiotoxicity
• Carditis
• Coronary artery aneurysm
• Coronary artery anomaly
• Coronary artery disease
• Spontaneous coronary artery dissection
• Coronary artery ectasia
• Coronary occlusion
• Coronary steal
• Coronary thrombosis
• Coronary vasospasm
• Cœur en sabot
• Coxsackievirus-induced cardiomyopathy

D

• Duke Treadmill Score
• Duroziez's disease

E

• Eisenmenger's syndrome
• Embryocardia
• Endocardial fibroelastosis
• Eosinophilic myocarditis

H

• Heart attack
• Heart failure
• Heart failure with preserved ejection fraction
• Heart to Heart (1949 film)
• High-output heart failure
• Hyperdynamic precordium

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

I

• Idiopathic giant-cell myocarditis
• Interventricular dyssynchrony
• Intraventricular dyssynchrony
• Isolated atrial amyloidosis

K

• Keshan disease

L

• Loeffler endocarditis

M

• Mydicar
• Myocardial bridge
• Myocardial disarray
• Myocardial rupture
• Myocardial scarring
• Myocardial stunning
• Myocarditis

N

• Nonbacterial thrombotic endocarditis

O

• OLR1
• Ostial disease

P

• Papillary fibroelastoma
• Pathophysiology of heart failure
• Postpericardiotomy syndrome
• Pulmonary vein stenosis

R

• Right axis deviation
• Roemheld syndrome

S

• Saturated fat and cardiovascular disease
• SCAR-Fc
• Shone's syndrome
• Strain pattern
• Subacute bacterial endocarditis
• Sudden cardiac death of athletes

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

T

• Traumatic cardiac arrest

V

• Ventricular aneurysm
• Vibroacoustic disease
• Viral cardiomyopathy

W

• Waon therapy